Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.

about

Highly Expressed Granulocyte Colony-Stimulating Factor (G-CSF) and Granulocyte Colony-Stimulating Factor Receptor (G-CSFR) in Human Gastric Cancer Leads to Poor Survival.

Item

http://www.wikidata.org/entity/Q54979422

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Highly Expressed Granulocyte C ...... Cancer Leads to Poor Survival.

@en

Highly Expressed Granulocyte Colony-Stimulating Factor

@nl

type

Item

label

Highly Expressed Granulocyte C ...... Cancer Leads to Poor Survival.

@en

Highly Expressed Granulocyte Colony-Stimulating Factor

@nl

prefLabel

Highly Expressed Granulocyte C ...... Cancer Leads to Poor Survival.

@en

Highly Expressed Granulocyte Colony-Stimulating Factor

@nl

P1476

Highly Expressed Granulocyte C ...... Cancer Leads to Poor Survival

@en

P2093

Bibo Tan

http://www.w3.org/2001/XMLSchema#string

Jing Zuo

http://www.w3.org/2001/XMLSchema#string

Kelei Hua

http://www.w3.org/2001/XMLSchema#string

Liqiao Fan

http://www.w3.org/2001/XMLSchema#string

Qiang Ji

http://www.w3.org/2001/XMLSchema#string

Qun Zhao

http://www.w3.org/2001/XMLSchema#string

Yong Li

http://www.w3.org/2001/XMLSchema#string

Zhisong Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor.

Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and 'emergency' hematopoiesis.

Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma

Early systemic granulocyte-colony stimulating factor treatment attenuates neuropathic pain after peripheral nerve injury.

G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.

Effects of granulocyte-colony stimulating factor and the expression of its receptor on various malignant cells

The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer.

P304

1701-1711

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.12659/MSM.909128

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29567938

http://www.w3.org/2001/XMLSchema#string

P932

5880331

http://www.w3.org/2001/XMLSchema#string